![](/img/cover-not-exists.png)
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor
Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.Volume:
233
Language:
english
Journal:
Psychopharmacology
DOI:
10.1007/s00213-016-4412-9
Date:
October, 2016
File:
PDF, 410 KB
english, 2016